Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. 2009

Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
Laboratory of Toxicology, College of Veterinary Medicine, Seoul National University, Seoul 151-742, Korea.

Tetrandrine (TET), a bis-benzylisoquinoline alkaloid from the root of Stephania tetrandra, is known to have anti-tumor activity in various malignant neoplasms. However, the precise mechanism by which TET inhibits tumor cell growth remains to be elucidated. The present studies were performed to characterize the potential effects of TET on phosphoinositide 3-kinase/Akt and extracellular signal-regulated kinase (ERK) pathways since these signaling pathways are known to be responsible for cell growth and survival. TET suppressed cell proliferation and induced apoptosis in A549 human lung carcinoma cells. TET treatment resulted in a down-regulation of Akt and ERK phosphorylation in both time-/concentration-dependent manners. The inhibition of ERK using PD98059 synergistically enhanced the TET-induced apoptosis of A549 cells whereas the inhibition of Akt using LY294002 had a less significant effect. Taken together, our results suggest that TET: i) selectively inhibits the proliferation of lung cancer cells by blocking Akt activation and ii) increases apoptosis by inhibiting ERK. The treatment of lung cancers with TET may enhance the efficacy of chemotherapy and radiotherapy and increase the apoptotic potential of lung cancer cells.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D044182 Benzylisoquinolines ISOQUINOLINES with a benzyl substituent. Benzyl-Isoquinoline,Benzylisoquinoline,Bis-Benzyl-Isoquinoline,Bis-Benzylisoquinoline,Bisbenzylisoquinoline,Bisbenzylisoquinolines,Benzyl-Isoquinolines,Bis-Benzyl-Isoquinolines,Bis-Benzylisoquinolines,Benzyl Isoquinoline,Benzyl Isoquinolines,Bis Benzyl Isoquinoline,Bis Benzyl Isoquinolines,Bis Benzylisoquinoline,Bis Benzylisoquinolines
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D048049 Extracellular Signal-Regulated MAP Kinases A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS. ERK MAP Kinase,ERK MAP Kinases,Extracellular Signal-Regulated Kinase,Extracellular Signal-Regulated Kinases,Extracellular Signal-Regulated MAP Kinase,MAP Kinases, Extracellular Signal-Regulated,Extracellular Signal Regulated Kinase,Extracellular Signal Regulated Kinases,Extracellular Signal Regulated MAP Kinase,Extracellular Signal Regulated MAP Kinases,Kinase, ERK MAP,Kinase, Extracellular Signal-Regulated,Kinases, Extracellular Signal-Regulated,MAP Kinase, ERK,MAP Kinases, Extracellular Signal Regulated,Signal-Regulated Kinase, Extracellular

Related Publications

Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
December 2002, International journal of oncology,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
April 2013, Oncology letters,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
April 2013, Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
April 2019, Naunyn-Schmiedeberg's archives of pharmacology,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
January 2017, Cancer cell international,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
June 2010, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
May 2004, Carcinogenesis,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
January 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
June 2018, International journal of molecular sciences,
Hyun Sun Cho, and Seung Hee Chang, and Youn Sun Chung, and Ji Young Shin, and Sung Jin Park, and Eun Sun Lee, and Soon Kyung Hwang, and Jung Taek Kwon, and Arash Minai Tehrani, and Minah Woo, and Mi Sook Noh, and Huda Hanifah, and Hua Jin, and Cheng Xiong Xu, and Myung Haing Cho
July 2015, Thoracic cancer,
Copied contents to your clipboard!